Spots Global Cancer Trial Database for Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers
Official Title: Randomized Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers
Study ID: NCT03232138
Conditions
Study Description
Brief Summary: This research study involves taking an experimental anti-cancer dietary supplement called Sulforaphane (SF) or a placebo (product without any supplement content) over a period of twelve months in order to determine if it is a useful dietary supplement for prevention of lung cancer in humans. The main goals of this research study are: 1. To learn about the effects of giving Sulforaphane (SF) to former smokers who are still at high risk of developing cancer due to their smoking history and whether or not their condition improves, stays the same or becomes worse after Sulforaphane (SF) is given. 2. To learn whether Sulforaphane (SF) might reverse some of the lung cell changes associated with future development of lung cancer.
Detailed Description:
Eligibility
Minimum Age: 55 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact Details
Name: Jian-Min Yuan, MD, PhD
Affiliation: Univesity of Pittsburgh
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
